SearchDictionaryMobileLogin

Obesity Hypoventilation Syndrome (Pickwickian Syndrome)

71  relevant articles (6 outcomes, 3 trials/studies) found for this Disease

Description: HYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night (HYPERSOMNOLENCE). It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.

Also Known As:
Pickwickian Syndrome; Syndrome, Pickwickian; Hypoventilation Syndrome, Obesity; Syndrome, Obesity Hypoventilation

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypoventilation
2. Obstructive Sleep Apnea
3. Weight Loss (Weight Reduction)
4. Sleep Apnea Syndromes (Sleep Apnea)
5. Hypertension (High Blood Pressure)

Experts

1. Grunstein, Ronald R: 2 articles (06/2007 - 01/2006)
2. Yee, Brendon J: 2 articles (06/2007 - 01/2006)
3. Piper, Amanda J: 2 articles (06/2007 - 01/2006)
4. Banerjee, Dev: 2 articles (06/2007 - 01/2006)
5. Redolfi, Stefania: 1 article (06/2007)
6. Dobroschke, Jakob: 1 article (06/2007)
7. Heinemann, Frank: 1 article (06/2007)
8. Budweiser, Stephan: 1 article (06/2007)
9. Corda, Luciano: 1 article (06/2007)
10. Pfeifer, Michael: 1 article (06/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Obesity Hypoventilation Syndrome:
1. Carbon MonoxideIBA
2. Carbon DioxideIBA
3. HormonesIBA
4. Medroxyprogesterone 17-Acetate (Depo-Provera)FDA LinkGeneric
5. OxygenIBA
6. Interleukin-6 (Interleukin 6)IBA
7. LeptinIBA
8. SASIBA
9. ProgesteroneFDA LinkGeneric
10. Oxyhemoglobins (Oxyhemoglobin)IBA
07/01/1985 - "Oxyhemoglobin saturation during sleep in subjects with and without the obesity-hypoventilation syndrome."
01/01/2008 - "Current recommendations follow: (1) APAP devices are not recommended to diagnose OSA; (2) patients with congestive heart failure, patients with significant lung disease such as chronic obstructive pulmonary disease; patients expected to have nocturnal arterial oxyhemoglobin desaturation due to conditions other than OSA (e.g., obesity hypoventilation syndrome); patients who do not snore (either naturally or as a result of palate surgery); and patients who have central sleep apnea syndromes are not currently candidates for APAP titration or treatment; (3) APAP devices are not currently recommended for split-night titration; (4) certain APAP devices may be used during attended titration with polysomnography to identify a single pressure for use with standard CPAP for treatment of moderate to severe OSA; (5) certain APAP devices may be initiated and used in the self-adjusting mode for unattended treatment of patients with moderate to severe OSA without significant comorbidities (CHF, COPD, central sleep apnea syndromes, or hypoventilation syndromes); (6) certain APAP devices may be used in an unattended way to determine a fixed CPAP treatment pressure for patients with moderate to severe OSA without significant comorbidities (CHF, COPD, central sleep apnea syndromes, or hypoventilation syndromes); (7) patients being treated with fixed CPAP on the basis of APAP titration or being treated with APAP must have close clinical follow-up to determine treatment effectiveness and safety; and (8) a reevaluation and, if necessary, a standard attended CPAP titration should be performed if symptoms do not resolve or the APAP treatment otherwise appears to lack efficacy."
Order ALL the reference details at left...

Therapies and Procedures

1. Continuous Positive Airway Pressure
2. Artificial Respiration (Mechanical Ventilation)
3. Positive-Pressure Respiration (PEEP)
4. Tracheostomy
5. Gastroplasty (Vertical-Banded Gastroplasty)

Best Treatments:
Research Summary Report
on Obesity Hypoventilation Syndrome
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 6 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>